Biallelic SMARCB1 mutations are frequently observed in malignant rhabdoid tumors (MRTs) and atypical teratoid rhabdoid tumors, which are aggressive and poorly differentiated pediatric tumors that occur predominately in the kidney or soft tissue and central nervous system, respectively.46 This evidence concerns the gene SMARCB1 and atypical teratoid rhabdoid tumor.